12th ASM Conference on Candida and Candidiasis

描述（由申请人提供）：念珠菌属是人类的主要真菌病原体，引起的疾病范围从口腔和阴道念珠菌病到危及生命的念珠菌血症和侵袭性疾病。念珠菌领域的重点是广泛的主题，涉及流行病学，耐药性，感染，宿主反应，疫苗和治疗。念珠菌和念珠菌病会议每两年举行一次，是介绍这些不同领域的前沿进展和最新观点的首要论坛。请求提供资金，为将于2014年3月26日至30日在路易斯安那州新奥尔良举行的第12届念珠菌和念珠菌病会议提供部分支持。会议将由美国微生物学会主办，该学会将提供管理专业知识和财政支持。该计划将基于过去的系列会议，这些会议已经吸引了大约400名美国和国际科学家的出席，并在参与者调查中得到了热情的支持。该计划将包括34名演讲者，他们在基础和/或临床真菌学方面的专业知识和62名演讲者，他们将根据提交的摘要进行选择。这一安排将提供灵活性，以介绍最先进的进展，并争取各种新兴和成熟的社区成员作为发言者。将有关于念珠菌病的流行病学，诊断和治疗的临床讲座，演讲者经过精心筛选，以确保和蔼可亲和有效性。这些会谈将被纳入会议，重点是念珠菌感染的各个关键方面，包括环境信号，抗真菌剂和耐药性，免疫识别，疫苗，形态发生和生物膜。在关于念珠菌病例报告的午餐会上，临床医生将告知基础科学家诊断和治疗不同类型感染的挑战。非正式平行会议将讨论感染模型，代谢适应，真菌药物相互作用和新技术，同时进一步鼓励富有成效的互动和讨论。每天下午将有一个海报会议，以便对将提交的250-300张海报进行充分讨论。我们相信，我们的目标-介绍该领域的最新进展，突出青年科学家（特别是妇女和少数民族）的成就，促进协同和跨学科的互动，并为社区范围的讨论提供场所-将得以实现。

DESCRIPTION (provided by applicant): Candida is the major fungal pathogen of humans, causing diseases that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida field focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, vaccines and therapeutics. The Candida and Candidiasis Conference, held every two years, is the premier forum for presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested to provide partial support for the 12th Conference on Candida and Candidiasis, which will be held from 26-30 March, 2014, in New Orleans, LA. The conference will be sponsored by the American Society for Microbiology, which will provide both management expertise and financial support. The program will be based upon past conferences in the series, which have reliably drawn attendance of around 400 American and International scientists, and have been met with enthusiastic support in participant surveys. This program will include 34 speakers chosen for their expertise in fundamental and/or clinical mycology and 62 speakers who will be selected based on submitted abstracts. This arrangement will provide the flexibility to present cutting-edge advances and to enlist a diverse spectrum of emerging and established community members as speakers. There will be clinical talks about the epidemiology, diagnosis, and treatment of candidiasis, with speakers carefully prescreened for affability and effectiveness. These talks will be incorporated into sessions that focus on various key aspects of candidal infections, including environmental signaling, antifungal agents and resistance, immune recognition, vaccines, morphogenesis, and biofilms. In a lunch session on Candida case reports, clinicians will inform basic scientists about the challenges of diagnosing and treating different types of infection. Informal parallel sessions will address infection models, metabolic adaptation, fungal drug interactions and new technologies while further encouraging productive interaction and discussion. There will be a poster session each afternoon to allow ample discussion of the 250-300 posters that will be presented. We are confident that our goals - to present the latest advances in the field, to spotlight achievements of junior scientists (especially women and minorities), to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion - will be achieved.